October 17, 2018 11:02 AM EDT

Novotech beefs up Asia-Pacific CRO offering with new buyout as region’s biopharma business booms

John Carroll

Editor & Founder

→ Asia-Pacific CRO Novotech is expanding, buying out CRO Clinical Network Services as it builds up its early- to late-stage trial network in the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Novotech beefs up Asia-Pacific CRO offering with new buyout as region’s biopharma business booms

John Carroll

Editor & Founder

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

BridgeBio shares promising results in trial of Canavan disease gene therapy

CRISPR therapy reduces swelling attacks by 81% in Intellia follow-up study

Facing lost rebates, MGM Resorts to stop covering GLP-1 weight loss shots

Exclusive: University of Toronto spinout raises $53.5M to create new obesity drugs with AI

Icon's quarterly earnings hit by biotech and pharma pullback

IDEAYA Biosciences: Targeting unmet market needs with precision oncology

Novotech beefs up Asia-Pa­cif­ic CRO of­fer­ing with new buy­out as re­gion’s bio­phar­ma busi­ness booms

Editor & Founder

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Novotech beefs up Asia-Pacific CRO offering with new buyout as region’s biopharma business booms